Lorna B. Woolford

Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors.

C.S. Potten, Gary Owen, Donna Hewitt et al. · Gut · 1995 · 142 citations · Full text

Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF).

Brian I. Lord, Lorna B. Woolford, Graham Molineux · PubMed · 2001 · 82 citations

Immunology, Pharmacotherapy, Metronomic Chemotherapy +20

Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4

Michael D. Milsom, Lorna B. Woolford, Geoffrey P. Margison et al. · Molecular Therapy · 2004 · 32 citations · Full text

Cell Therapy, Immunology, Vivo Selection +19

The P140K mutant of humanO6-methylguanine-DNA-methyltransferase (MGMT) confers resistancein vitro andin vivo to temozolomide in combination with the novel MGMT inactivatorO6-(4-bromothenyl)guanine

Lorna B. Woolford, Thomas D. Southgate, Geoffrey P. Margison et al. · The Journal of Gene Medicine · 2005 · 32 citations

Chemoprevention Strategy, Methylating Agent Temozolomide, Molecular Biology +22

Apoptosis in bone marrow cells of mice with different p53 genotypes after gamma-rays irradiation in vitro.

Yufang Cui, Ping‐Kun Zhou, Lorna B. Woolford et al. · PubMed · 1995 · 25 citations

Gamma-rays Irradiation, Radiation Effect, Apoptosis +18